Venture capital funding for Irish technology SMEs has experienced a significant downturn, with a reported 58% decline in the first quarter of 2026, totaling €221.7 million raised. This sharp drop follows a record-setting period last year, where funding exceeded half a billion euro.
According to the latest VenturePulse survey from the Irish Venture Capital Association (IVCA) and William Fry, the life sciences sector has emerged as the leading area for investment, accounting for 54% of the total funding. Despite the overall decline, international investors played a crucial role, contributing 85% of the capital raised, indicating both a reliance on outside funding and a robust interest in quality Irish tech firms.
While artificial intelligence (AI) is a hot topic globally, representing a significant portion of venture capital investment, it accounted for only 2% of the funding in Ireland. This figure may underestimate AI's influence, as many companies utilizing AI are categorized by their primary industry rather than their technological components. Notably, the funding landscape saw declines across various deal sizes, particularly in mid-range transactions, while early-stage investments under €1 million showed relative resilience.
Looking forward, market sentiment remains uncertain due to geopolitical factors, but local policy initiatives, such as increased state support and a new €250 million Seed and Venture Capital Scheme, may provide some stabilization. The largest transactions of the quarter highlight the ongoing strength of Ireland's life sciences and deep tech sectors, suggesting that while overall funding may be down, investors are still selectively backing companies with strong technological foundations and scalability potential.